Fred Alger Management, LLC Neogenomics Inc Transaction History

Fred Alger Management, LLC

$20.2 Billion
Q2 2025

A detailed history of Fred Alger Management, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Fred Alger Management, LLC holds 806,649 shares of NEO stock, worth $7.82 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

806,649

Previous 1,574,777 48.78%

Holding current value

$7.82 Million

Previous $14.9 Million 60.55%

% of portfolio

0.03%

Previous 0.09%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$6.4 - $10.27 $4.92 Million - $7.89 Million	-768,128 Reduced 48.78%	806,649 $5.9 Million
Q1 2025 May 15, 2025	SELL	$9.09 - $18.61 $1.26 Million - $2.57 Million	-138,182 Reduced 8.07%	1,574,777 $14.9 Million
Q4 2024 Feb 14, 2025	SELL	$13.0 - $18.43 $909,194 - $1.29 Million	-69,938 Reduced 3.92%	1,712,959 $28.2 Million
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $697,001 - $922,225	-52,015 Reduced 2.83%	1,782,897 $26.3 Million
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $6.57 Million - $7.96 Million	-504,854 Reduced 21.58%	1,834,912 $25.5 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $6.52 Million - $7.79 Million	463,936 Added 24.73%	2,339,766 $36.8 Million
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $6.35 Million - $11.3 Million	544,130 Added 40.86%	1,875,830 $30.4 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $4.36 Million - $6.41 Million	359,120 Added 36.92%	1,331,700 $16.4 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $13.7 Million - $19.3 Million	972,525 Added 1768227.25%	972,580 $15.6 Million
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $6.84 Million - $14.6 Million	-752,150 Reduced 99.99%	55 $0
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $5.69 Million - $10.6 Million	-881,699 Reduced 53.96%	752,205 $6.95 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $8.33 Million - $13.7 Million	1,060,294 Added 184.85%	1,633,904 $14.1 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $1.86 Million - $3.68 Million	-263,361 Reduced 31.47%	573,610 $4.68 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $151,170 - $438,953	-12,442 Reduced 1.46%	836,971 $10.2 Million
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $425,609 - $676,871	-13,959 Reduced 1.62%	849,413 $29 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $48.4 Million - $61.1 Million	-1,162,746 Reduced 57.39%	863,372 $41.6 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $8.01 Million - $11.3 Million	-218,847 Reduced 9.75%	2,026,118 $91.5 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $9.76 Million - $14.1 Million	234,760 Added 11.68%	2,244,965 $108 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $5.27 Million - $8.26 Million	146,187 Added 7.84%	2,010,205 $108 Million
Q3 2020 Nov 13, 2020	BUY	$33.26 - $40.48 $9.9 Million - $12 Million	297,563 Added 19.0%	1,864,018 $68.8 Million
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $18.5 Million - $23.7 Million	765,549 Added 95.59%	1,566,455 $48.5 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $12 Million - $20.2 Million	586,202 Added 273.03%	800,906 $22.1 Million
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $2.36 Million - $3.71 Million	124,259 Added 137.39%	214,704 $6.28 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $677,708 - $930,076	35,445 Added 64.45%	90,445 $1.73 Million
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $136,990 - $168,700	7,000 Added 14.58%	55,000 $1.21 Million
Q1 2019 May 14, 2019	BUY	$12.14 - $20.46 $582,720 - $982,080	48,000 New	48,000 $982,000

Others Institutions Holding NEO

# of Institutions

308

Shares Held

127M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.22B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Neogenomics Inc Transaction History